The Journal of Palliative Medicine’s “Tell Us More: The Palliative Care Oral History Project,” seeks to tell the story of Hospice and Palliative Care through informal interviews with pivotal leaders in the field. In each episode, hosts Dr. Ricky Leiter and Dr. Billy Rosa and research assistant Dr. Yilong Peng sit down with an HAPC luminary and do what our field does best – ask questions, listen, and reflect. In the first episode, Drs. Leiter and Rosa interviewed Dr. Betty Ferrell, Director of Nursing Research and Education and a Professor at City of Hope Medical Center in Duarte, California. What follows is a transcript of their conversation, edited lightly for clarity.

Dr. Autorino will discuss some of the findings of the ROBUUST trial looking at Upper Tract Urothelial Carcinoma.

This episode we host 3 international BPH experts and have a case-based panel discussion about all treatments for BPH.

With the increasing use of flexible ureteroscopy for the treatment of kidney stones, there is an increasing risk of complications. Join Dr. Stern, Dr. Monga and Dr. Bhojani as they discuss all aspects of intra renal pressure and its possible implications.

In this episode we discuss the contemporary use of mini PCNL. The panelists including Dr. Gupta and Dr. Knoll explain what they are currently doing in their respective practices and discuss the future of Mini PCNL with the technological evolution in kidney stone disease surgery.

In this episode, two experts in endourology discuss the non-clinical aspects of single-use scopes such as environmental impact and purchasing decisions.

In this episode I discuss with Dr Lipkin various aspects of ureteroscopy that may affect outcome and complication rates.

In this episode we learn about the DARRT method of PCNL: a near-zero fluoroscopy technique for gaining access to the kidney.

Amongst the many options for treatment of enlarged prostate, aquablation is growing in popularity. Dr. Netsch offers his expertise in discussing this technology.

With the increased popularity and success of focal therapy for prostate cancer, we hear from two international experts and what the challenges are of establishing and maintaining programs after training in the United States.